TARDBP and amyotrophic lateral sclerosis: It would be highly informative to extend studies of TDP‐43 phosphorylation to larger patient cohorts, as well as all disease subtypes (ALS, FTD‐TDP‐43 type A, B, C and D, AD with TDP‐43 pathology and LATE), and to correlate them with structural approaches, such as cryo‐EM or structural proteomics approaches.